2022 CVS Caremark Formulary Updates

Building on our decade of exceptional value and care

Our decade of market leadership implementing formulary innovations — from drug removals to new-to-market evaluations, from Tier 1 to indication-based strategies — continues. Each year we evolve our formulary strategies to keep clients ahead of a rapidly changing market. Such an innovative approach to formulary management has helped save our clients tens of billions of dollars.

Negotiating discounts from manufacturers, as well as developing and implementing proactive solutions — such as utilizing generic and biosimilar drugs to drive competition within a therapy class — are some of the many ways we continue to focus on helping our clients save money.

Committed to innovation and delivering results

2012 Formulary removals	2015 New-to- market evaluations	2016 Specialty class review	2017 Indication based strategy	2018 Value-based strategy	2019 Tier-1 strategy	2020 Quarterly review and/or update
Hyperinflation management

Hyperinflation management

2012 Formulary removals

2015 New-to-market evaluations

2016 Specialty class review

2017 Indication based strategy

2018 Value-based strategy

2019 Tier-1 strategy

2020 Quarterly review and/or update

Continuing to deliver value in 2022

2022 Standard Control Formulary Changes**

The changes we are making effective January 1, 2022 will help ensure our formulary strategies remain the most impactful tool for clients seeking to better manage costs.

	20 drugs removed; 4 drugs added back***
	2 drugs added to Tier 1 strategy
	Tier 1 strategy expected to deliver average savings of 31% per claimSavings projection reflects weighted average savings based on Q22021 clients with standard formulary exclusions.
	99.61% of members will not be impacted by the formulary removals

Ensuring plan member access, affordability and convenience

We remain motivated to keep member costs low so they can afford their medications, work toward minimal member disruption and maximize member experience. Our formulary updates for 2022 ensure that 99.61 percent of members will not be impacted with changes.

Those members — and their prescribers — impacted by the removals will receive proactive communications to help with a seamless transition. We educate them on medications that will no longer be covered as well as clinically appropriate formulary options.

CVS Health is committed to providing a clinically sound formulary that drives lowest net cost for clients while ensuring members have affordable access to the drugs they need to manage their health.